Qiming Venture Partners

Qiming Venture Partners

Signal active

Investment Firm

Overview

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.

Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Highlights

Founded

2006

Industry

Financial Services

Employees

51-100

Investment

960

Lead Investment

517

Exits

78

Stages

Early Stage Venture, Late Stage Venture, Seed, Private Equity

Investor Type

Venture Capital

Location

Asia

Contact Information

Social

Profile Resume

Qiming Venture Partners, established in 2006 and headquartered in Asia., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Social Media, Virtualization, Developer Platform, Financial Services, Venture Capital, Finance, Consumer, Health Care, Mobile, SaaS. The organization boasts a portfolio of 946 investments, with an average round size of $40.1M and 78 successful exits. Their recent investments include Nurien Software, New Enterprise Associates, Globespan Capital Partners, Kaixin001, Ceyuan Ventures. The highest investment round they participated in was $1783.3B. Among their most notable exits are Nurien Software and New Enterprise Associates. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Nisa Leung

Nisa Leung

Managing Partner

imagePlace Kuantai Yeh

Kuantai Yeh

Partner

imagePlace Gary Rieschel

Gary Rieschel

Founder & Managing Partner

imagePlace -- --

-- --

Founder & CEO

imagePlace Alex Zhou

Alex Zhou

Partner

imagePlace William Hu

William Hu

Managing Partner

Investment portfolio

Qiming Venture Partners has made 960 investments. Their most recent investment was on Aug 06, 2024, when Dr.Clear Aligner raised $14.0M.

Qiming Venture Partners has made 22 diversity investments. Their most recent diversity investment was on Mar 20, 2024, when Emulate raised $47.1M.

investments

960

Diversity investments

22

Lead investments

517

Number of exits

78

Investments

960

Annouced DateOrganization NameIndustryMoney Raised
Jul 14, 2024
AusperBio AusperBio
Biotechnology37.0M
Jul 30, 2024
LTZ Therapeutics LTZ Therapeutics
Biotechnology20.0M
Aug 06, 2024
Dr.Clear Aligner Dr.Clear Aligner
Health Care14.0M
Aug 07, 2024--2.8M

Exits

78

Funding Timeline

Funding rounds

960

Investors

0

Funds

18

Funding Rounds

960

Qiming Venture Partners has raised 960 rounds. Their latest funding was raised on Aug 07, 2024 from a Seed Round - Chenzhang Biotechnology round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jul 14, 2024
Series A - AusperBio Series A - AusperBio
-37.0M-
Jul 30, 2024
Series A - LTZ Therapeutics Series A - LTZ Therapeutics
-20.0M-
Aug 06, 2024
Series A - Dr.Clear Aligner Series A - Dr.Clear Aligner
-14.0M-
Aug 07, 2024
Seed Round - Chenzhang Biotechnology Seed Round - Chenzhang Biotechnology
-2.8M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.